Parents of teens who can become pregnant should expect two clinic pregnancy tests before isotretinoin starts. iPLEDGE, the FDA safety program for isotretinoin, requires the first test at prescribing and a second test after 30 days.
According to the National Community Pharmacists Association, FDA approved iPLEDGE changes on February 9, 2026, in this FDA approval summary. The changes take effect August 9, 2026, to ease paperwork while keeping safeguards. For parents, that means confirming where tests occur, how birth control is recorded, and when pickup happens.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- When do the two pretreatment tests happen?
- What should parents ask the prescriber?
- What should parents ask the pharmacy?
- What changed for testing during treatment?
When do the two pretreatment tests happen?
According to the FDA Contraception Counseling Guide in this contraception counseling guide, patients who can become pregnant need a first screening test at the prescribing decision. A second confirmatory test follows after a 30-day wait. Both results must be negative before the first dose.
According to the FDA medical-organizations letter in this medical-organizations letter, all pregnancy testing before the first dose must occur in a medical setting. That includes a prescriber office, clinic, or laboratory. Home tests do not count for this pretreatment step.
What should parents ask the prescriber?
According to the FDA iPLEDGE fact sheet, isotretinoin is for patients age 12 and older with severe recalcitrant nodular acne. It applies when other therapies, including antibiotics, have not worked. All patients, prescribers, and pharmacies must be registered in iPLEDGE.
According to a Clinics in Dermatology ethics review in this ethics review summary, isotretinoin carries an estimated 20%-35% risk of congenital defects. Patients who can become pregnant must use two simultaneous birth-control methods or abstain. The requirement covers one month before, during, and one month after therapy.
- Ask which two methods fit your teen or whether abstinence will be documented.
- Ask where each pretreatment test will be collected and how results reach iPLEDGE.
- Ask what counseling confirmation your teen must complete before each fill.
What should parents ask the pharmacy?
According to the Honeydew Health patient guide, the prescriber must confirm the negative test and counseling in iPLEDGE. The patient must then answer comprehension questions. Only then may the pharmacy dispense the prescription.
Each fill is limited to no more than a 30-day supply for pickup within seven days of specimen collection. According to Medaptly reporting on the FDA action, the old 19-day lockout after a missed pickup window is gone. A repeat pregnancy test can now requalify the prescription immediately.
What changed for testing during treatment?
According to the National Community Pharmacists Association, prescribers may allow home pregnancy tests during and after treatment. The prior requirement for CLIA-certified laboratory testing was removed. Pretreatment tests remain clinic-based.
Ask the prescriber whether home tests will be accepted once treatment starts. Ask the pharmacy what test date starts the pickup clock. Keep test receipts and appointment dates together to avoid a missed window.
You Might Also Like
- Pretreatment Pregnancy Testing Under iPLEDGE in 2026: Pregnancy Testing Questions for Parents of Teens With Severe Acne
- Planned Home Pregnancy Testing Under the 2026 iPLEDGE Changes: Pharmacy and Prescriber Questions for Parents of Teens With Severe Acne
- Pediatric Acne and Rosacea at the 2026 AAD Annual Meeting: Scarring and Pigment-Change Questions for Parents of Teens With Acne